Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DHX9 is a member of the DExH-box family of RNA and DNA helicases. It is an NTP-dependent enzyme that catalyzes the unwinding of both double-stranded DNA and RNA as well as hybrid structures such as R-loops and G-quadruplexes. The protein plays central roles in multiple aspects of nucleic acid metabolism, including transcription, translation, replication, splicing, microRNA biogenesis, transport, and DNA repair. DHX9 is overexpressed in several cancer types; depletion leads to antiproliferative effects on various cancer cell lines. Mutations or dysregulation can also contribute to neurological disorders due to its essential role in neuronal RNA metabolism.
ATP-dependent unwinding of DNA and RNA duplexes, resolution of R-loops, D-loops, triplex DNA, and G-quadruplexes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DExH-box helicase 9 (DHX9).